Fu Yue Wen, Wu De Pei, Cen Jian Nong, Feng Yu Feng, Chang Wei Rong, Zhu Zi Ling, Qiu Qiao Chen, Zhu Ping
Department of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Eur J Haematol. 2007 Aug;79(2):138-45. doi: 10.1111/j.1600-0609.2007.00885.x. Epub 2007 Jul 2.
Successful allogeneic hematopoietic stem cell transplantation (HSCT) requires reconstitution normal T-cell immunity. Measurement of T-cell receptor excision circles (TRECs) and T-cell receptor beta (TCRBV) CDR3 repertoire is a means of quantifying recent thymic T-cell production and reflecting antigen-specific T-cell clones proliferation.
We used real-time quantitative PCR to detect TRECs from 43 Chinese patients who underwent three kind of allo-HSCT without T-cell depletion. RT-PCR was performed to amplify 24 subfamily genes of TCRBV in 24 patients of them.
For haploidentical-D group, the TRECs numbers were lower up to 24 months. For matched-sibling donor (MSD) group, the recovery of TRECs was faster than those of other two groups. TRECs values in matched-unrelated donor (MUD) were in the middle. During 2-19 months after transplantation, there were 6-16 BV subfamilies expressed and 33-48% of them were polyclones. The usage rate of TCRBV and percentage of polyclones in haploidentical-D were less than those of other two groups. Twenty-three CDR3 molecules were obtained from nine patients who were potentially associated with GVHD or CMV infection.
Analyzing the changes of TCRBV repertoire and measuring TRECs during immune reconstitution would be useful to determine the host's current immune status and ability of T-cell immune reconstitution and also to find antigen-specific T-cell clones in the three kinds of HSCT.
成功的异基因造血干细胞移植(HSCT)需要重建正常的T细胞免疫。测量T细胞受体切除环(TRECs)和T细胞受体β(TCRBV)CDR3库是量化近期胸腺T细胞产生并反映抗原特异性T细胞克隆增殖的一种方法。
我们使用实时定量PCR检测了43例未进行T细胞去除的三种异基因HSCT的中国患者的TRECs。对其中24例患者的TCRBV的24个亚家族基因进行了RT-PCR扩增。
对于单倍体相合-D组,TRECs数量在24个月内一直较低。对于同胞全相合供者(MSD)组,TRECs的恢复比其他两组更快。无关全相合供者(MUD)组的TRECs值处于中间水平。移植后2至19个月期间,有6至16个BV亚家族表达,其中33%至48%为多克隆。单倍体相合-D组的TCRBV使用率和多克隆百分比低于其他两组。从9例可能与移植物抗宿主病(GVHD)或巨细胞病毒(CMV)感染相关的患者中获得了23个CDR3分子。
分析TCRBV库的变化并在免疫重建过程中测量TRECs,有助于确定宿主当前的免疫状态和T细胞免疫重建能力,也有助于在三种HSCT中找到抗原特异性T细胞克隆。